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ABSTRACT
Hermansky-Pudlak Syndrome (HPS) is a rare autosomal recessive disorder that 
presents with oculocutaneous albinism, bleeding disorders, and immunodeficien-
cy. Granulomatous colitis and pulmonary fibrosis are two major complications 
of this syndrome. On rare instances, HPS can involve the heart and lungs. This 
report discusses a 32-year-old man who presented with oculocutaneous albinism 
and immunodeficiency along with renal, pulmonary, and pancreatic complica-
tions. Pancreatic atrophy is a unique finding in our patient, which has not been 
reported in the literature. The purpose of our case report is to bring into light 
unusual complications of HPS so that timely action could be taken to avoid the 
progression of complications. 
INTRODUCTION
Hermansky-Pudlak Syndrome (HPS) usually presents as 
oculocutaneous albinism, bleeding diathesis, and pulmo-
nary fibrosis (PF). The disease was first described in 1959 
and was named after Frantisek Hermansky and Pavel Pud-
lak [1]. HPS is a rare autosomal recessive disorder which is 
predominantly seen in northwest Puerto Rican populations 
[2]. The incidence of disease in the Puerto Rican popula-
tion is 1/500,000. It most commonly occurs sporadically in 
the Indian sub-continent. Pulmonary fibrosis is usually di-
agnosed late in the disease process and is the major cause 
of early death. There are 10 different types of HPS based 
on 10 different genetic associations [3]. Here, we describe a 
37-year-old male patient who was diagnosed with HPS and 
had developed pancreatic, renal, and pulmonary complica-
tions. This is the first case report of HPS in which we see 
pancreatic complications. 
CASE PRESENTATION
A 32-year-old non-smoker male from Afghanistan present-
ed to North-West General Hospital Peshawar in 2014, with 
severe shortness of breath and dry cough for one week. The 
shortness of breath was present at rest. On physical examina-
tion, he was in respiratory distress, using accessory muscles 
of respiration, and cyanotic. Jugular venous pressure was 
normal. The patient had no pedal edema. Hand examination 
revealed clubbing present in all fingers. Chest examination 
showed bilateral diffuse inspiratory crackles and prolonged 
expiration with expiratory rhonchi. Oxygen saturation on 
pulse oximetry was 92% on room air. Chest radiograph re-
vealed bilateral reticular patterns that were predominant in 
the lower zone, highly suggestive of interstitial lung disease. 
A high-resolution computed tomography scan of lungs was 
ordered which showed reticular opacities in both lungs and 
areas of subpleural honeycombing. On spirometry, the lung 
volumes showed a severe restrictive pattern with forced vi-
tal capacity (FVC) of 27% of the predicted. He was acutely 
managed with high flow oxygen, salbutamol and ipratropi-
um nebulization, and intravenous steroid.
On detailed medical history and review of medical records, 
we found that the patient had dry cough refractory to bron-
chodilator therapy since 2008, which was progressively get-
ting worse. Two years later in 2010, the patient developed 
shortness of breath on exertion. At that time, his electrocar-
diogram, echocardiogram, and computed tomography brain 
scan were normal, but his high resolution computed tomog-
raphy of the chest showed diffusely distributed small cysts in 
bilateral lung parenchyma predominantly on the left side. He 
was treated symptomatically with antibiotics and anti-tus-
sive and was advised for regular follow-up. A year forward, 
in 2011, the patient developed type 1 respiratory failure, 
which was managed with corticosteroids and long-term ox-
ygen therapy. In 2012, repeat computed tomography scans 
showed areas of interstitial thickening with a honey-comb 
appearance and mild fibrosis suggestive of interstitial lung 
disease. 
Past medical history was significant for recurrent infections, 
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2which include left otitis media in 2010 and urinary tract in-
fection, which were treated with carbapenems. The patient 
was also diagnosed with hydronephrosis of the right kidney 
and chronic pyelonephritis of left kidney. His previous com-
puted tomography report revealed extrahepatic portal hyper-
tension and atrophy of body and tail of the pancreas. The 
patient had been hospitalized multiple times in Afghanistan, 
Pakistan, and India from 2010 to 2014.
It was noted that his problems started 15 years back, with 
gradually increasing photophobia, eye pain, and decreased 
vision for which he had taken treatment from local doctors 
in Afghanistan. 
General examination showed that the patient had hypopig-
mentation of hair and skin (Figure 1) and clubbing of fin-
gers. The eye examination revealed nystagmus of both eyes. 
A fundal analysis showed bilateral hypopigmented fundus 
and hypoplastic fovea.
Multiple Congenital Anomalies and G6PD Deficiency
ing melanosomes and dense platelet granules are involved in 
the pathogenesis of this syndrome [5]. The albinism causes 
congenital nystagmus and decreased visual acuity as well as 
transillumination of the iris and hypopigmentation of skin and 
hair [6]. Our patient presented with hypopigmented skin and 
ocular findings, which were typical of HPS. Recurrent otitis 
media and urinary tract infection define immunodeficiency 
due to ceroid accumulation in neutrophils.
Our patient presented with respiratory findings of HPS. In 
HPS, respiratory complications typically occur in the third 
and fourth decade of life [7]. Pathogenesis of pulmonary in-
volvement in HPS includes dysfunctional alveolar epithelial 
cells, which leads to increased production of monocyte che-
moattractant protein (MCP-1). MCP-1 leads to reactivation 
and recruitment of lung macrophages, which produce trans-
forming growth factor-b (TGF-b). TGF-b amplifies fibrotic 
cascade, causing alveolar epithelial cells apoptosis and stimu-
lation of fibrotic remodeling. Several cases on the pulmonary 
involvement of HPS had been reported. Sugino et al. reported 
a 30-year-old HPS patient who had pulmonary fibrosis as well 
as emphysema [8]. Kelil et al. reported a 30-year-old HPS pa-
tient who presented with pulmonary fibrosis [9]. Our patient 
presented with the same complications as the above-men-
tioned patients. 
Our patient also presented with renal complications. Re-
nal findings include hydronephrosis of the right kidney and 
chronic pyelonephritis of left kidney. Chronic pyelonephritis 
in our patient could be the result of immunodeficiency where-
as hydronephrosis of the right kidney might be the result of 
renal stones. Abdullah et al. described a 55-year-old HPS pa-
tient who developed end-stage renal disease due to interstitial 
deposits of ceroid lipofuscin [10]. Gordilla et al. described 
another case of HPS who had stage II chronic kidney disease 
and developed focal segmental glomerulosclerosis later in life 
[11]. Our patient presented with different renal manifestations 
of HPS which had never before been reported.
Besides typical clinical features of HPS and respiratory and 
renal findings, our patient also had portal hypertension and 
atrophy of the head and neck of the pancreas. To the best of 
our knowledge, this is the first case report which mentions 
pancreatic involvement in HPS. The mechanism behind pan-
creatic atrophy is unknown. A possible explanation can be the 
accumulation of ceroid lipofuscin, an amorphous lipid-protein 
complex, in biliary or pancreatic duct or within pancreatic pa-
renchyma, which could cause pancreatic atrophy in the same 
way as ceroid lipofuscin causes pulmonary fibrosis [12]. Pa-
tients with HPS should undergo screening for pancreatic in-
volvement early in the disease process to avoid progression of 
pancreatic complication.
All patients with albinism should be searched for other find-
ings of HPS, and if found positive, they should be started on 
early treatment. More research needs to be done to understand 
pathogenesis and invent definitive therapy for lysosomal stor-
age disease and ceroid lipofuscin deposition to avoid compli-
cations of HPS.
The storage pool defect is because of the absence of platelet 
dense bodies, which has adenosine diphosphate, adenosine tri-
phosphate, calcium, and serotonin inside it, and is responsible 
for secondary aggregation response of platelets [13]. Patients 
Figure 1: Hypopigmentation of skin and hairs
Laboratory test analysis was significant for slightly elevated 
urea and creatinine. Blood urea nitrogen levels were 51mg/
dl and, creatinine was 1.30mg/dl. 
Based on above-mentioned findings, our patient was diag-
nosed with Hermansky Pudlak Syndrome. He was counseled 
about the diagnosis, its course, and prognosis. He was treat-
ed symptomatically and discharged home on medications 
and long-term oxygen therapy.
DISCUSSION
We presented a case of a 32-year-old male who came in with 
oculocutaneous albinism, immunodeficiency, pulmonary, re-
nal, and pancreatic complications of Hermansky-Pudlak Syn-
drome. Hermansky-Pudlak Syndrome (HPS) is an autosomal 
recessive disorder which is characterized by oculocutaneous 
albinism, a storage-pool deficiency, and lysosomal accumula-
tion of ceroid lipofuscin [4]. Mutations in the gene involved 
in packaging and formation of specialized lysosomes includ-
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with HPS have easy bruising of soft tissues and prolonged 
bleeding after dental extraction and surgical procedures; pro-
phylaxis with desmopressin can be effective [14]. Luckily, 
our patient did not present with bleeding, and bleeding time 
was normal. Avoidance of aspirin products is essential. The 
accumulation of ceroid lipofuscin, an amorphous lipid-protein 
complex, is associated with pulmonary fibrosis and granulo-
matous colitis [15-16]. 
CONCLUSION
Hermansky-Pudlak syndrome should be considered in the 
differential diagnoses in patients presenting with respiratory 
symptoms in addition to oculocutaneous albinism. Our pa-
tient presented with pulmonary, renal, and pancreatic com-
plications along with other usual clinical findings. HPS can 
involve multiple organs of the body so patients should be 
actively screened for pulmonary, renal and pancreatic com-
plications.
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